Bluejay Diagnostics (BJDX) Cash from Investing Activities (2021 - 2026)
Bluejay Diagnostics recorded quarterly Cash from Investing Activities of -$15314.0 in Q1 2026, down 1261.24% quarter-over-quarter from -$1125.0 in Q4 2024.
Bluejay Diagnostics' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$15314.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$15314.0; the TTM figure through Mar 2026 stood at -$286664.0 (changed N/A YoY), while the FY2025 annual figure was -$173735.0, up 43.37% from the prior year.
- Cash from Investing Activities came in at -$15314.0 for Q1 2026 at Bluejay Diagnostics, down from -$1125.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$227.0 in Q3 2024 to a low of -$791464.0 in Q3 2022.
- A 4-year average of -$171194.8 and a median of -$87894.0 in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slumped 18392.15% in 2022 and soared 99.7% in 2024, its largest moves.
- Bluejay Diagnostics' Cash from Investing Activities stood at -$238207.0 in 2022, then surged by 63.1% to -$87894.0 in 2023, then soared by 98.72% to -$1125.0 in 2024, then sank by 1261.24% to -$15314.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$15314.0, -$1125.0, and -$227.0 for Q1 2026, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | -15,314.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,314.00 |
| Mar 31, 2026 | -15,314.00 |
| Dec 31, 2024 | -1,125.00 |
| Dec 31, 2024 | -1,125.00 |
| Sep 30, 2024 | -227.00 |
| Sep 30, 2024 | -227.00 |
| Jun 30, 2024 | -269,998.00 |
| Jun 30, 2024 | -269,998.00 |
| Mar 31, 2024 | -35,433.00 |
| Mar 31, 2024 | -35,433.00 |
| Dec 31, 2023 | -87,894.00 |
| Dec 31, 2023 | -87,894.00 |
| Sep 30, 2023 | -74,498.00 |
| Sep 30, 2023 | -74,498.00 |
| Jun 30, 2023 | -201,105.00 |
| Jun 30, 2023 | -201,105.00 |
| Mar 31, 2023 | -340,669.00 |
| Mar 31, 2023 | -340,669.00 |
| Dec 31, 2022 | -238,207.00 |
| Dec 31, 2022 | -238,207.00 |
| Sep 30, 2022 | -791,464.00 |
| Sep 30, 2022 | -791,464.00 |
| Jun 30, 2022 | -123,253.00 |
| Jun 30, 2022 | -123,253.00 |
| Mar 31, 2022 | -46,346.00 |
| Mar 31, 2022 | -46,346.00 |
| Dec 31, 2021 | -17,733.00 |
| Dec 31, 2021 | -17,733.00 |
| Sep 30, 2021 | -4,280.00 |
| Sep 30, 2021 | -4,280.00 |